We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Automatic Data Processing
ADP
$106B
| $254K | 0.03% |
+2,320
| New | +$248K |
|
402
Republic Services
RSG
$66.6B
| $251K | 0.03% |
+3,794
| New | +$247K |
|
403
Arch Capital
ACGL
$37.2B
| $246K | 0.03% |
7,500
-75,900
| -91% | -$2.45M |
|
|
SIVB
404
DELISTED
SVB Financial Group
SIVB
| $245K | 0.03% |
1,311
-4,200
| -76% | -$739K |
|
|
HRC
405
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $244K | 0.03% |
3,300
+1,700
| +106% | +$131K |
|
406
Raymond James Financial
RJF
$34B
| $236K | 0.03% |
4,200
+3,900
| +1,300% | +$210K |
|
407
Idexx Laboratories
IDXX
$44.9B
| $233K | 0.03% |
1,500
-10,800
| -88% | -$1.71M |
|
408
Brookfield
BN
$104B
| $231K | 0.03% |
+15,648
| New | +$219K |
|
|
WAGE
409
DELISTED
WageWorks, Inc.
WAGE
| $231K | 0.03% |
+3,800
| New | +$231K |
|
410
Credicorp
BAP
$30.9B
| $229K | 0.03% |
1,116
-800
| -42% | -$157K |
|
|
MYOK
411
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $223K | 0.03% |
+5,200
| New | +$166K |
|
412
Avnet
AVT
$7.07B
| $215K | 0.03% |
5,475
-29,300
| -84% | -$1.12M |
|
413
Canadian Natural Resources
CNQ
$92.2B
| $215K | 0.03% |
+13,081
| New | +$200K |
|
414
Skyworks Solutions
SWKS
$9.73B
| $213K | 0.03% |
2,093
-14,700
| -88% | -$1.52M |
|
415
NextEra Energy
NEE
$186B
| $212K | 0.03% |
+5,800
| New | +$212K |
|
416
Consolidated Edison
ED
$41.3B
| $210K | 0.03% |
+2,600
| New | +$215K |
|
417
Franklin Resources
BEN
$17.3B
| $209K | 0.03% |
+4,700
| New | +$206K |
|
418
Ligand Pharmaceuticals
LGND
$5.94B
| $204K | 0.02% |
+2,405
| New | +$190K |
|
419
G-III Apparel Group
GIII
$1.55B
| $203K | 0.02% |
+7,000
| New | +$184K |
|
420
Avery Dennison
AVY
$12.9B
| $201K | 0.02% |
+2,048
| New | +$193K |
|
421
Spectrum Brands
SPB
$2.08B
| $201K | 0.02% |
+1,900
| New | +$214K |
|
|
IMMU
422
DELISTED
Immunomedics Inc
IMMU
| $196K | 0.02% |
+14,000
| New | +$140K |
|
423
Builders FirstSource
BLDR
$7.93B
| $182K | 0.02% |
+10,100
| New | +$163K |
|
|
AKS
424
DELISTED
AK Steel Holding Corp
AKS
| $163K | 0.02% |
29,161
+800
| +3% | +$4.57K |
|
|
ARRY
425
DELISTED
Array Biopharma Inc
ARRY
| $137K | 0.02% |
11,100
+9,400
| +553% | +$87.3K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.